Applied Veterinary Clinical Nutrition 2023
DOI: 10.1002/9781119375241.ch11
|View full text |Cite
|
Sign up to set email alerts
|

Nutritional Management of Gastrointestinal Diseases

Nick Cave,
Sean J. Delaney,
Jennifer A. Larsen
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 317 publications
0
2
0
Order By: Relevance
“…There are not many studies in the literature evaluating the effect of the use of beta-glucans in skin diseases in dogs. Beynen et al (2011) [ 18 ] developed a double-blind, placebo-controlled trial study, with the same type of beta-glucan. For 8 weeks, dogs of several breeds received complete dry food with/without 800 ppm of beta-glucans (16 dogs in control group and 15 dogs in test group) and their clinical signs were evaluated by the owners.…”
Section: Beta-glucans For the Skinmentioning
confidence: 99%
See 1 more Smart Citation
“…There are not many studies in the literature evaluating the effect of the use of beta-glucans in skin diseases in dogs. Beynen et al (2011) [ 18 ] developed a double-blind, placebo-controlled trial study, with the same type of beta-glucan. For 8 weeks, dogs of several breeds received complete dry food with/without 800 ppm of beta-glucans (16 dogs in control group and 15 dogs in test group) and their clinical signs were evaluated by the owners.…”
Section: Beta-glucans For the Skinmentioning
confidence: 99%
“…These chronic diseases are widely represented in the veterinary routine. Atopic dermatitis is the second most prevalent dermatitis in dogs [ 16 ]; osteoarthritis is found in 80% of dogs over eight years of age [ 17 ]; and inflammatory bowel disease is the most common chronic gastrointestinal disease in dogs and cats [ 18 ]. Despite the growing number of research about the positive immunomodulatory effects of beta-glucans, many of those have conflicting results and methodology biases such as the absence of the treatment individualization or homogeneity of experimental groups.…”
Section: Introductionmentioning
confidence: 99%